New treatment in breast cancer metastatic and pretreated

被引：0
|
作者：
Di Cristina, L
Cirrito, D
Vitello, S
机构：
[1] Serv Oncol, Alcamo, TP, Italy
[2] Osped S Elia Caltanissetta, Serv Oncol, Caltanissetta, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E26
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [21] Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer
    Onyenadum, A.
    Gogas, H.
    Kosmidis, P.
    Aravantinos, G.
    Bafaloukos, D.
    Bacoyiannis, H.
    Markopoulos, C.
    Koutras, A.
    Tzorakoelefterakis, E.
    Makatsoris, T.
    Fountzilas, G.
    Kalofonos, H. P.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (02) : 192 - 198
  • [22] What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer? - Reply
    Keller, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6261 - 6261
  • [23] Single-agent capecitabine: A reference treatment for taxane-pretreated metastatic breast cancer?
    Seidman, AD
    O'Shaughnessy, J
    Misset, JL
    ONCOLOGIST, 2002, 7 : 20 - 28
  • [24] The Palliative CMF is a Reasonable Salvage Treatment Option in Heavily Pretreated Patients With Metastatic Breast Cancer
    Park, J.
    Lim, Y.
    Lee, K. H.
    Han, S. W.
    Oh, D. Y.
    Im, S. A.
    Kim, T. Y.
    Bang, Y. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S346 - S346
  • [25] Everolimus in combination with carboplatin: a promising treatment with low toxicity in heavily pretreated metastatic breast cancer
    Schwarzlose-Schwarck, S.
    Regierer, A. C.
    Martus, P.
    Schulz, C. -O.
    Liu, H.
    Schefe, J. H.
    Possinger, K.
    Scholz, C. W.
    Eucker, J.
    ONKOLOGIE, 2011, 34 : 118 - 118
  • [26] Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer
    Laessig, D.
    Stemmler, H. J.
    Vehling-Kaiser, U.
    Fasching, P. A.
    Melchert, F.
    Koelbl, H.
    Stauch, M.
    Maubach, P.
    Scharl, A.
    Morack, G.
    Meerpohl, H.
    Weber, B.
    Kalischefski, B.
    Heinemann, V.
    ONCOLOGY, 2007, 73 (5-6) : 407 - 414
  • [27] Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer
    Onyenadum, A.
    Gogas, H.
    Markopoulos, C.
    Bafaloukos, D.
    Aravantinos, G.
    Mantzourani, M.
    Koutras, A.
    Tzorakoelefterakis, E.
    Xiros, N.
    Makatsoris, T.
    Fountzilas, G.
    Kalofonos, H. P.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (05) : 582 - 589
  • [28] A new HER2-targeted therapeutic option for pretreated patients with metastatic breast cancer
    Banys-Paluchowski, M.
    ONKOLOGE, 2020, 26 (06): : 561 - 563
  • [29] Gemcitabine and carboplatin in heavily pretreated metastatic breast cancer: predictive value of breast cancer subtypes
    Natoli, G.
    Nelli, F.
    Moscetti, L.
    D'Auria, G.
    Signorelli, C.
    Chilelli, M. G.
    Padalino, D.
    Massari, A.
    Ruggeri, E. M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 279 - 279
  • [30] Treatment of metastatic breast cancer
    Welt, Anja
    Decker, Thomas
    Poettgen, Christoph
    ONKOLOGE, 2022, 28 (SUPPL 1): : 61 - 63
12345